Report cover image

Top 300 Bio CDMO - Facility Index and Biomanufacturers Subscription Database

Published Apr 01, 2024
SKU # DFAQ19414229

Description

The only Global Contract Development and ManufacturingFacilities Database subscription that actively tracks over 400+dedicated CDMO facilities providing development andmanufacturing services for biopharmaceuticals.

Hundreds of facilities manufacturing clinical andcommercial scale biologics, account for $16.89 billionin services sales in 2023, growing at 17% annually.

Based on 30 years of evaluating and benchmarking the biopharmaceutical and life sciences industry, this database is updatedcontinually and includes comprehensive information and insights.

Top300Bio CDMO Facility Index ranks each ‘dedicated’ CDMO facility and providesregional quantitative analysis of biomanufacturing regions and clusters.
  • Total bioreactor liter capacity
  • CDMO/CMO service expertise
  • Future Biomanufacturing capacity coming online
  • Number of commercial and clinical biological products manufactured
  • Revenue estimates
  • Strengths and Challenges
  • Technologies and expertise, and much more

Table of Contents

How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.